Status:

COMPLETED

Nitrate and Vitamin C on Vascular Health Oxidative Stress

Lead Sponsor:

David Travis Thomas

Conditions:

Endothelial Dysfunction

Eligibility:

All Genders

50-70 years

Phase:

NA

Brief Summary

The objective of this study is to examine whether the co-administration of dietary nitrate combined with vitamin C for 4 weeks in patients at risk for CVD would yield robust effects on endothelial fun...

Detailed Description

This is a 10 week randomized, cross-over, double-blinded, placebo-controlled study. This study was designed to compare the magnitude changes in RHI (primary outcome), plasma NO metabolites (nitrate an...

Eligibility Criteria

Inclusion

  • Age: between 50 and 70 years
  • Body mass index (BMI) of 18.5-34.9 kg/m2
  • Reactive hyperemia index (RHI) of \< or equal to 2
  • High cholesterol levels with LDL concentrations (\>130 mg/dL)
  • Not receiving any lipid lowering therapy.
  • Non-smokers

Exclusion

  • Evidence of overt atherosclerotic disease (i.e., documented medical history of coronary artery disease, peripheral artery disease, cardiovascular disease, and stroke).
  • Any surgery or medical history that could confound study results, such as a history of bowel resection, rheumatoid arthritis, inflammatory bowel disease, celiac disease, diabetes, uncontrolled hypertension (systolic blood pressure \>160 mm Hg or diastolic blood pressure \>100 mm Hg), controlled hypertension on clonidine medication.
  • Participants were ineligible if they had been diagnosed with the following medical conditions such as active cancer, severe anemia (Hb \< 10mg/dL), hepatic or renal disease, heart failure, or finger deformities.
  • HIV-positive patients on combination antiretroviral therapy because of potential pharmacokinetic interactions with beetroot juice were excluded.
  • Participants were also excluded if they reported taking any form of hormone replacement therapy (estrogens, progesterone, and testosterone), multivitamin supplements that provides \>100% of RDA, or any of the following medications that attenuate nitrate conversion to NO: proton pump inhibitors (PPI) and antibiotics.
  • Participants who consumed greater than 6 drinks of alcohol (any form) per week, performed structured resistance or aerobic training for more than 1-hour four times per week, or participated in other clinical intervention within the previous 30 days were excluded from the study.
  • Eligible subjects were asked to avoid using the mouthwash before and throughout the study duration. In addition, enrolled participants were advised to consume low- vitamin c diet throughout the study. They were provided at the beginning of the study with a list of high vitamin C foods/fortified foods to avoid during the study.

Key Trial Info

Start Date :

February 5 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 13 2019

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT04283630

Start Date

February 5 2018

End Date

December 13 2019

Last Update

February 25 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Kentucky

Lexington, Kentucky, United States, 40514

2

University of Kentucky

Lexington, Kentucky, United States, 40536